This is a working overview of reverse-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-04-17 and is reviewed periodically as new material appears.
Quality checks after reconstitution include visual inspection, pH measurement, and analytical methods such as reversed-phase high-performance liquid chromatography. These tests can detect insoluble material, degradation products, and changes in concentration. Mass spectrometry is often used to confirm molecular identity when the peptide sequence is known. Because a clear solution can still contain aggregates or modified peptide, visual clarity alone is not sufficient. Analytical results are compared with a reference standard or the pre-reconstitution certificate of analysis.
Container selection matters because peptides can adsorb to glass, plastic, and filter membranes. Low-binding polypropylene tubes reduce losses for hydrophobic sequences, and filtration through a 0.22 µm membrane can remove particulates and microorganisms. Some peptides may bind to certain filter materials, so compatibility should be checked. Aliquots should be prepared before freezing to avoid repeated temperature cycling. Labels should record the peptide identity, lot number, solvent, concentration, reconstitution date, and storage condition.
After reconstitution, the peptide solution is less stable than the dried powder because water enables hydrolysis, oxidation, and microbial growth. Storage temperature, pH, buffer composition, and container material all affect how long the solution remains usable. Many peptides are kept at 2–8 °C for short-term work, while frozen aliquots at −20 °C or below are used for longer intervals. Repeated freeze-thaw cycles can cause aggregation or precipitation. The choice of storage condition should be based on stability data for the specific peptide.
Once reconstituted, a peptide solution is generally less stable than the dry powder. Hydrolysis, oxidation, aggregation, and microbial growth can change the preparation over time, so storage temperature and duration are practical concerns. Dividing a solution into single-use aliquots before freezing can reduce repeated freeze-thaw cycles, which may otherwise cause precipitation or loss of activity. The optimal storage conditions vary by peptide, and no single rule applies to all sequences. Records of solvent, concentration, date, and storage history help maintain traceability. Studies often report stability under defined conditions rather than universal shelf lives.
Reconstitution is the process of dissolving a lyophilized peptide powder in a suitable liquid to produce a solution for laboratory or clinical use. The dry powder is typically a porous cake or fluffy solid formed by freeze-drying an aqueous or mixed-solvent preparation. Adding solvent restores the peptide to a dissolved state, but the result is not necessarily identical to the original pre-lyophilization solution. Factors such as pH, ionic strength, temperature, and the peptide's sequence influence how completely and quickly dissolution occurs. The term is distinct from dilution, which lowers concentration without changing the physical state of an already dissolved material.
| Property | Value | Notes |
|---|---|---|
| Lyophilized storage | −20 °C or below | Sealed container with desiccant limits moisture ingress. |
| Reconstituted storage | 2 to 8 °C short term | Freezing aliquots at −20 °C or below may extend stability for some peptides. |
| Preferred container | Low-binding polypropylene | Reduces adsorption losses compared with untreated glass. |
| Sterilization method | 0.22 µm filtration | Filter material compatibility should be verified for each peptide. |
| Common label data | Peptide, lot, date, concentration | Supports traceability and avoids repeated freeze-thaw cycles. |
Documentation supports reproducibility and traceability. Records often include lot number, solvent composition, final concentration, preparation date, and storage location. Such details help distinguish procedural variation from actual sample instability. Questions remain about how best to predict long-term stability from short-term accelerated studies, because peptide degradation pathways differ widely. For many peptides, the relationship between in vitro solution stability and biological behavior is incompletely understood and is an active area of research.
After reconstitution, a peptide solution is typically stored under conditions that limit degradation. Cool temperatures slow hydrolysis and oxidation, while freezing can preserve samples for longer periods. Repeated freeze-thaw cycles may promote aggregation or precipitation, so aliquoting before freezing is a common laboratory practice. The optimal storage temperature depends on the peptide sequence, buffer composition, and expected duration. Solutions containing oxidizable residues may benefit from inert gas overlays or antioxidants, though compatibility with the specific peptide must be considered.
Quality control of reconstituted peptides combines visual inspection with instrumental analysis. A clear solution does not prove correct identity or purity, and a cloudy solution does not always indicate failure. Reverse-phase high-performance liquid chromatography can separate the peptide from related impurities, while mass spectrometry confirms molecular mass and detects modifications. pH measurement and osmolality checks provide additional information about the solution environment, and documentation of lot number, solvent, and storage history supports traceability.
After a peptide is reconstituted, handling practices affect its chemical and physical stability over time. Aqueous solutions can support microbial growth unless they are prepared with aseptic technique or contain preservatives. Container material matters because peptides can adsorb to glass or plastic surfaces, reducing the amount available in solution. Repeated transfers increase exposure to air and potential contaminants, and temperature fluctuations can accelerate degradation. These factors are separate from the peptide's intrinsic sequence-based stability.
Storage conditions for reconstituted peptides are product-specific. Cool temperatures slow many degradation pathways, but freezing can concentrate solutes and promote aggregation. Light exposure can oxidize susceptible residues such as methionine, cysteine, or tryptophan. Oxygen in headspace can contribute to oxidation, while acidic or basic pH can drive hydrolysis and deamidation. The best storage condition for a given sequence is often determined empirically because general rules do not capture all sequence-specific effects.
Buffer components and ionic strength affect how a peptide dissolves and remains in solution. Some sequences require a defined pH range to avoid precipitation or aggregation, while others tolerate pure water. The optimal conditions are often determined empirically because solubility cannot be predicted reliably from sequence alone. Even when a peptide dissolves, the resulting solution may contain aggregates that are not visible to the eye. Analytical methods such as reversed-phase high-performance liquid chromatography and mass spectrometry are used to confirm identity and purity after reconstitution.
Peptide reconstitution is the process of dissolving a dried peptide preparation in a liquid solvent to form a solution. Many peptides are supplied as lyophilized powders because removing water improves stability during shipping and storage. The dried material may appear as a cake, flake, or loose powder depending on the manufacturing and drying method. Reconstitution restores the peptide to a liquid state so that it can be further diluted, analyzed, or handled in laboratory workflows. The term is distinct from dilution, which lowers concentration after a solution already exists.
The choice of solvent depends on the peptide's sequence, charge, and solubility profile. Water is common for hydrophilic peptides, while aqueous mixtures containing acetonitrile, methanol, or a small amount of acid may be needed for hydrophobic or basic sequences. Adding the liquid to the powder, rather than the reverse, can reduce clumping and improve wetting. Gentle mixing or brief vortexing may help, but vigorous agitation can create foam and shear sensitive structures. Complete dissolution is judged by a clear solution with no visible particles.
Quality control after reconstitution often includes visual inspection for particulates, pH measurement, and concentration determination by ultraviolet absorbance at 280 nm when aromatic residues are present. Reverse-phase high-performance liquid chromatography can assess purity and reveal degradation peaks. Mass spectrometry confirms molecular identity and detects modifications such as oxidation or truncation. Size-exclusion chromatography can quantify aggregates and oligomers. These methods are established for many peptides but may require optimization for hydrophobic or chemically modified sequences.
Microbial contamination is a concern for aqueous peptide solutions, especially those without preservatives. Bacteriostatic water contains an antimicrobial preservative and is used in some laboratory settings, while sterile water lacks preservatives. Filtration through a sterile filter can reduce particulates and microbes, but some peptides adsorb to filter membranes. The effect of preservatives on peptide stability is peptide-dependent and not fully predictable. Documentation of lot number, solvent, date, and storage conditions supports traceability and reproducibility.
After reconstitution, peptide solutions are generally less stable than lyophilized powders, and hydrolysis, oxidation, deamidation, and aggregation can occur in solution. Stability depends on peptide sequence, concentration, pH, buffer composition, temperature, light exposure, and dissolved oxygen. Many research protocols store reconstituted solutions at 4 °C for short periods or at -20 °C or -80 °C for longer periods. Repeated freeze-thaw cycles can promote aggregation and loss of activity. The optimal storage condition is peptide-specific and often determined empirically rather than predicted from sequence alone.
In Chadwick's words, "...In order to explain the great penetrating power of the radiation we must further assume that the particle has no net charge..." The existence of the neutron was first postulated by Rutherford in 1920, and in the words of Chadwick, "...how on earth were you going to build up a big nucleus with a large positive charge? And the answer was a neutral particle." Subsequently, he communicated his findings in more detail. In the words of Richard Rhodes, referring to the neutron, "It would therefore serve as a new nuclear probe of surpassing power of penetration." Philip Morrison stated, "A beam of thermal neutrons moving at about the speed of sound...produces nuclear reactions in many materials much more easily than a beam of protons...traveling thousands of times faster." According to Rhodes, "Slowing down a neutron gave it more time in the vicinity of the nucleus, and that gave it more time to be captured." Fermi's team, studying radiative capture which is the emission of gamma radiation after the nucleus captures a neutron, studied sixty elements, inducing radioactivity in forty. In the process, they discovered the ability of hydrogen to slow down the neutrons. Enrico Fermi and his colleagues in Rome studied the results of bombarding uranium with neutrons in 1934. Fermi concluded that his experiments had created new elements with 93 and 94 protons, which the group dubbed ausenium and hesperium.
Through the Luebering–Rapoport pathway bisphosphoglycerate mutase catalyzes the transfer of a phosphoryl group from C1 to C2 of 1,3-BPG, giving 2,3-BPG. 2,3-bisphosphoglycerate, the most concentrated organophosphate in the erythrocyte, forms 3-PG by the action of bisphosphoglycerate phosphatase. The concentration of 2,3-BPG varies proportionately with the pH, since it is inhibitory to catalytic action of bisphosphoglycerate mutase. Under physiological conditions, the flux through the Rapoport-Luebering shunt is 19% of the main glycolytic flux.
Reactions of acids are often generalized in the form HA ⇌ H+ + A−, where HA represents the acid and A− is the conjugate base. This reaction is referred to as protolysis. The protonated form (HA) of an acid is also sometimes referred to as the free acid. Acid–base conjugate pairs differ by one proton, and can be interconverted by the addition or removal of a proton (protonation and deprotonation, respectively). The acid can be the charged species and the conjugate base can be neutral in which case the generalized reaction scheme could be written as HA+ ⇌ H+ + A. In solution there exists an equilibrium between the acid and its conjugate base. The equilibrium constant K is an expression of the equilibrium concentrations of the molecules or the ions in solution. Brackets indicate concentration, such that [H2O] means the concentration of H2O. The acid dissociation constant Ka is generally used in the context of acid–base reactions. The numerical value of Ka is equal to the product (multiplication) of the concentrations of the products divided by the concentration of the reactants, where the reactant is the acid (HA) and the products are the conjugate base and H+.
Both agonist and antagonist bond the same active site. Adding agonist dose can reverse the effect of reversible competitive antagonism. Irreversible competitive antagonism occurs when the antagonist binds to the same spot on the receptor as the agonist but dissociates from the receptors very slowly or not. As a result, when the agonist is delivered, there is no change in the antagonist occupancy. Since a receptor can only hold one molecule at a time, competitive antagonists can reduce the agonist occupancy (percentage of receptors to which the agonist is bound). Raising the agonist concentration can bring back the agonist occupancy and the subsequent tissue response due to their competition. Thus, the opposition is surmountable. The amount to which the competitive antagonist causes the agonist log concentration–effect curve to shift to the right while maintaining its maximum slope is a measure of the dosage ratio. The antagonist concentration causes the dosage ratio to rise linearly.
Preclinical laboratory studies analogous to those conducted on the pro-malignant effects of 12(S)-HETE and growth-inhibiting effects of blocking 12-HETE production in cultured prostate cancer cell lines, have implicated 12-HETE (stereoisomer sometimes undefined) in cancer cell lines from various other human tissues including those from the liver, intestinal epithelium, lung, breast, skin (melanoma), ovary, pancrease, and possibly bladder. These studies implicate the interaction of 12-HETE with BLT2 receptors in intestinal epithelium cancer cells, and BLT2 receptors in breast, ovary, pancreas, and bladder cancer cells. While the studies on these tissues have not been as frequent or diverse as those on prostate cancer cell lines, they are suggested to indicate that 12-HETE contributes to the growth or spread of the corresponding cancer in humans.
Sources: en.wikipedia.org
Supergrade 2–3% Weapons grade 3–7% Fuel grade 7–18% Reactor grade 18% or more A nuclear reactor that is used to produce plutonium for weapons therefore generally has a means for exposing 238U to neutron radiation and for frequently replacing the irradiated 238U with new 238U. A reactor running on unenriched or moderately enriched uranium contains a great deal of 238U. However, most commercial nuclear power reactor designs require the entire reactor to shut down, often for weeks, in order to change the fuel elements. They therefore produce plutonium in a mix of isotopes that is not well-suited to weapon construction. Such a reactor could have machinery added that would permit 238U slugs to be placed near the core and changed frequently, or it could be shut down frequently, so proliferation is a concern; for this reason, the International Atomic Energy Agency inspects licensed reactors often. A few commercial power reactor designs, such as the reaktor bolshoy moshchnosti kanalniy (RBMK) and pressurized heavy water reactor (PHWR), do permit refueling without shutdowns, and they may pose a proliferation risk. By contrast, the Canadian CANDU heavy-water moderated, natural-uranium fueled reactor can also be refueled while operating, but it normally consumes most of the 239Pu it produces in situ; thus, it is not only inherently less proliferative than most reactors, but can even be operated as an "actinide incinerator".
== Production and occurrence == Pentane is produced by fractional distillation of petroleum and purified by rectification (successive distillations). It occurs in alcoholic beverages and in hop oil. It is a component of exhaled breath for some individuals. A degradation product of unsaturated fatty acids, its presence is associated with some diseases and cancers. Pentane is a relatively minor component of automobile gasoline, with its share varying within 1–6% in 1990s Sweden, 2–13% in 1990s US and 1–3% in the US in 2011. At 62, its octane number (both RON and MON) is quite low.
For the 1994–95 season, Barnsley turned to midfielder Danny Wilson to manage the club. His first season brought a sixth-place finish in the First Division, which would normally have meant a play-off place, but a restructuring of the league meant that they missed out. They finished 10th a year later before finally emerging as serious promotion contenders in the 1996–97 season, finally clinching runners-up spot and automatic promotion and gaining the top flight place that they had spent 99 years trying to win. Barnsley lasted just one season in the Premier League but they did reach the quarter-finals of the FA Cup, defeating Manchester United in the fifth round. They also made their record signing that season with Georgi Hristov for £2 million. Wilson then departed to take over at Sheffield Wednesday, being succeeded as Barnsley manager by striker John Hendrie, who had been a key player in the promotion-winning team. Barnsley were the only team from outside the Premier League to reach the quarter-finals of the FA Cup in the 1998–99 season, but only finished 13th in the league. Hendrie was then replaced as manager by Dave Bassett, who rejuvenated the team and took them to fourth place in 1999–2000. The team lost in the play-off final to Ipswich Town, the last play-off final at Wembley before the stadium was closed for redevelopment.
As such, GGT elevations lack the necessary specificity to be a useful confirmatory test for cholestasis. Importantly, conjugated hyperbilirubinemia is present in 80% of patients with extrahepatic cholestasis and 50% of patients with intrahepatic cholestasis. Given that many patients with hyperbilirubinemia may not have cholestasis, the measurement of bilirubin levels is not a good diagnostic tool for identifying cholestasis. In a later stage of cholestasis aspartate transaminase (AST), alanine transaminase (ALT) and unconjugated bilirubin may be elevated due to hepatocyte damage as a secondary effect of cholestasis.
=== Activation by protease and metalloprotease === Plasmin and a member of matrix metalloproteinases (MMP) play a key role in promoting tumor invasion and tissue remodeling by inducing proteolysis of several ECM components. The TGF-β activation process involves the release of the LLC from the matrix, followed by further proteolysis of the LAP to release TGF-β to its receptors. MMP-9 and MMP-2 are known to cleave latent TGF-β. The LAP complex contains a protease-sensitive hinge region which can be the potential target for this liberation of TGF-β. Despite the fact that MMPs have been proven to play a key role in activating TGF-β, mice with mutations in MMP-9 and MMP-2 genes can still activate TGF-β and do not show any TGF-β deficiency phenotypes, this may reflect redundancy among the activating enzymes suggesting that other unknown proteases might be involved.
Sources: en.wikipedia.org
In molecular biology, pseudo amino acid composition (PseACC) is a method introduced by Kuo-Chen Chou to convert the protein sequence into a numerical vector for enhancing pattern recognition techniques, such as during discrimination between classes of proteins based on their sequences (e.g. between membrane proteins, transmembrane proteins, cytosolic proteins, and other types). This method represented an advance beyond using the immediate amino acid composition (AAC). Instead, the protein is characterized into a matrix of amino-acid frequencies. This matrix incorporates not only amino acid composition, but can also incorporate information from local features of the protein sequence. Due to the success and widespread application of the PseACC method, it was extended to address sequence-order effects in nucleotide compositions, giving rise to a comparative method called PseKNC.
== Medical uses == Diazoxide is used as a vasodilator in the treatment of acute hypertension or malignant hypertension. Diazoxide also inhibits the secretion of insulin by opening ATP-sensitive potassium channel of beta cells of the pancreas; thus, it is used to counter hypoglycemia in disease states such as insulinoma (a tumor producing insulin) or congenital hyperinsulinism.
=== Mechanism of action === At therapeutic concentrations, ixazomib selectively and reversibly inhibits the protein proteasome subunit beta type-5 (PSMB5) with a dissociation half-life of 18 minutes. This mechanism is the same as of bortezomib, which has a much longer dissociation half-life of 110 minutes; the related drug carfilzomib, by contrast, blocks PSMB5 irreversibly. Proteasome subunits beta type-1 and type-2 are only inhibited at high concentrations reached in cell culture models. PSMB5 is part of the 20S proteasome complex and has enzymatic activity similar to chymotrypsin. It induces apoptosis, a type of programmed cell death, in various cancer cell lines. A synergistic effect of ixazomib and lenalidomide has been found in a large number of myeloma cell lines.
In an effort to prevent incidents such as the disappearance of Malaysia Airlines Flight MH370, a new standard has been issued requiring all commercial aircraft to report their position every 15 minutes to air traffic controllers regardless of the country of origin. Introduced in 2016 by the ICAO, the regulation has no initial requirement for any new aircraft equipment to be fitted. The standard is part of a long-term plan, called the Global Aeronautical Distress and Safety System (GADSS), which will require new aircraft to be equipped with data broadcast systems that are in constant contact with air traffic controllers. The GADSS is similar to the Global Maritime Distress and Safety System (GMDSS) used for maritime safety.
The encapsulins are a family of bacterial proteins that serve as the main structural components of encapsulin nanocompartments. There are several different encapsulin proteins, including EncA, which forms the shell, and EncB, EncC, and EncD, which form the core. They are found in bacteria and archaea. They serve as intracellular structures that compartmentalize specific biochemical reactions. They are highly versatile systems and protect cargo proteins from environmental damage and optimize the efficiency of enzymatic processes. Encapsulins are used in synthetic biology, microbiology, structural biology, nanotechnology, and biotechnology. They are hard to discover due to their similarity to phage proteins.
Sources: en.wikipedia.org
Short-term storage is often at 2 to 8 °C, while longer storage may use frozen aliquots at −20 °C or below. Repeated freeze-thaw cycles should be avoided because they can promote aggregation.
Cloudiness may indicate incomplete dissolution, aggregation, or precipitation. Gentle mixing, pH adjustment, or filtration can sometimes resolve it, but the cause should be identified before use.
Bacteriostatic water contains a preservative that can interfere with some assays or react with certain peptides. Sterile water or a defined buffer may be preferable depending on the downstream application.
It means adding liquid to a lyophilized peptide powder so it dissolves into solution. The dry powder is not a finished liquid product, and the resulting concentration depends on the volume added. Complete dissolution should be visually confirmed before use.